A., Rolph T., Knott M., and Dubourg J., FGF21 Agonists: An Emerging Therapeutic for Metabolic DysfunctionAssociated Steatohepatitis and Beyond, Journal of Hepatology 81, no
Many patients and providers use them off-label for weight management, but this off-label status means insurance coverage for weight loss is harder to obtain, and manufacturer savings cards may not apply unless you have a diabetes diagnosis
To avoid issues, ensure theyre frozen solid when you go through security
ask your healthcare provider about specific fluid recommendations if you have heart or kidney disease
Alternatives which are available in Singapore although supply may be an issue
Theres a new safety signal (dysesthesia, an abnormal skin sensation) that wasnt seen in earlier trials